Responses to dupilumab (Dupixent) treatment were consistent across racial and ethnic groups in children with atopic dermatitis. “The results of this study suggest that race and ethnicity do not ...

in Japan has granted marketing and manufacturing authorization for Dupixent ® (dupilumab) for the treatment of chronic obstructive pulmonary disease (COPD) in adults whose disease is not ...